HomeDrug ClassesmTOR Inhibitors

mTOR Inhibitors: Uses, Common Brands, and Safety Info

mTOR inhibitors are a class of drugs that target the mTOR protein, used in immunosuppression, cancer treatment, and managing genetic disorders. Common brands include Everolimus and Sirolimus. Side effects may include mouth sores, diarrhea, and increased infection risk. Close monitoring and communication with healthcare providers is important.

mTOR Inhibitors

mTOR inhibitors, also known as mammalian target of rapamycin inhibitors, are a class of medications used in the treatment of various conditions. These drugs work by targeting a protein called mTOR, which plays a crucial role in regulating cell growth, proliferation, and survival. By inhibiting mTOR, these medications can help control abnormal cell growth associated with certain diseases.


mTOR inhibitors have a wide range of uses in different medical fields. One of the primary uses of mTOR inhibitors is in immunosuppression. These drugs are commonly prescribed to prevent organ transplant rejection, as they suppress the immune response and reduce the chances of the body rejecting the transplanted organ.

In addition, mTOR inhibitors are used in the treatment of certain types of cancer. These medications have shown effectiveness in treating kidney cancer, breast cancer, and neuroendocrine tumors. By blocking the mTOR protein, they can slow down the growth and spread of cancer cells, potentially improving outcomes for patients.

Furthermore, mTOR inhibitors have demonstrated efficacy in the management of rare genetic disorders such as tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM). In TSC, mTOR inhibitors can help shrink benign tumors in various organs, including the brain, heart, and kidneys. In LAM, these medications can help improve lung function and slow disease progression.

Common Brands

There are several commonly prescribed mTOR inhibitors available on the market today. Everolimus and sirolimus are two examples of drugs belonging to this class. Everolimus is used in the treatment of breast cancer, kidney cancer, pancreatic neuroendocrine tumors, TSC, and LAM. Sirolimus is primarily utilized in immunosuppression for organ transplants and is also used in certain rare conditions like TSC and LAM.


As with any medication, mTOR inhibitors carry some potential risks and side effects. Common side effects may include mouth sores, diarrhea, rash, fatigue, and elevated cholesterol levels. Less common but more serious side effects may include infections, lung problems, and an increased risk of developing certain types of cancer.

Due to their immunosuppressive properties, mTOR inhibitors can weaken the immune system, making it harder for the body to fight off infections. It is important for patients taking these drugs to regularly monitor their health and promptly report any concerning symptoms to their healthcare provider.

Before starting mTOR inhibitors, it is crucial for patients to inform their healthcare provider about any existing medical conditions, medications, or allergies they may have. This will help ensure the safe and appropriate use of these medications.

In conclusion, mTOR inhibitors are a class of medications that target the mTOR protein, playing a significant role in cell growth and survival. They have various uses in immunosuppression, cancer treatment, and the management of genetic disorders. However, it is essential to understand the potential risks and side effects associated with these drugs and closely follow healthcare provider instructions for safe use.

List of mTOR Inhibitors